International Journal of Bacteriology · 2016 · 45 citations · 22 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceAntimicrobial Resistance EpidemiologyMedical MicrobiologyAntibacterial ResistanceAntibiotic ResistanceAntibiotic Resistance MechanismsBacterial InfectionsMultidrug ResistanceResistance EpidemiologyBacterial Multidrug ResistanceClindamycin TherapyCommunity-acquired Methicillin-resistant Staphylococcus Aureus InfectionDrug Resistance PatternsHealthcare-associated ResistanceMethicillin ResistanceResistance Mechanisms In StaphylococciTherapeutic Treatment Management
Background. Methicillin-resistant Staphylococcus aureus (MRSA) has created significant epidemiological, infection-control, and therapeutic management challenges during the past three decades. Aim. To analyze the pattern of resistance of healthcare- and community-associated MRSA in Egypt and the trend of resistance of HA-MRSA over time (2005-2013). Methods. MRSA isolates were recovered from healthcare-associated (HA) and community-associated (CA) Staphylococcus aureus (S. aureus) infections. They were tested against 11 antimicrobial discs and the minimal inhibitory concentration (MIC) of vancomycin was determined. Inducible clindamycin resistance (iMLSB) was also screened using D-test. Findings. Of 631 S. aureus, MRSA was identified in 343 (76.6%) and 21 (11.5%) of HA and CA S. aureus isolates, respectively. The proportion of HA-MRSA increased significantly from 48.6% in 2005 to 86.8% in 2013 (p value < 0.001). Multidrug resistance (MDR) was observed in 85.8% of HA-MRSA and 48.6% of CA-MRSA. Vancomycin intermediate resistant S. aureus (VISA) was detected in 1.2% of HA-MRSA and none was detected in CA-MRSA. Among HA-MRSA strains, 5.3% showed iMLSB compared to 9.5% among CA-MRSA. Conclusion. The upsurge of the prevalence rates of HA-MRSA over time is alarming and urges for an effective infection control strategy and continuous monitoring of antimicrobial use.
22
Hsin Huang, Neil M. Flynn, Jeff H. King et al. · Journal of Clinical Microbiology · 2006 · 184 citations · Full text
Life Sciences, Infectious Diseases, Antimicrobial Resistance +16
M.A. Borg, Marlieke E.A. de Kraker, Elizabeth Scicluna et al. · Journal of Antimicrobial Chemotherapy · 2007 · 140 citations · Full text
Veterinary Medicine, Infectious Diseases, Antimicrobial Resistance +9